2026 NPPES data Psychiatry Physician NPI 1114042462 M.D.
Verify on CMS →

David Brozyna, M.D.

Psychiatry Physician in Rutherford, New Jersey.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 53,171 in Psychiatry Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
979
Medicare Part D claims · 77 beneficiaries · Psychiatry Physician avg: 1K
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$296.93
13 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

David Brozyna, M.D. filed 979 Medicare Part D claims in 2023 as a Psychiatry Physician in Rutherford, New Jersey, prescribing 90% generic.

979
Part D claims, 2023
90%
generic prescribing
$296.93
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

David Brozyna, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

979 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

David Brozyna, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about David Brozyna, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/19/2007

NPI 1114042462

Primary specialty

Psychiatry Physician

High-volume

53,171 US NPIs in this specialty

Medicare Part D claims

979 6% vs specialty avg

2023 prescription claims

Specialty avg: 1,038

Specialty distribution in New Jersey

How Psychiatry Physician compares to other specialties among New Jersey providers

New Jersey providers
Mental Health Counselor - 6.2%Mental Health Counselor6.2%Physical Therapist - 5.9%Physical Therapist5.9%Clinical Social Worker - 5.5%Clinical Social Worker5.5%Student in an Organized Health Care Education/Training Program - 5.4%Student in an Organized Health Care Education/Training Program5.4%Pharmacist - 5%Pharmacist5%Internal Medicine Physician - 3.1%Internal Medicine Physician3.1%Psychiatry Physician - 0.9%Psychiatry Physician0.9%
Largest specialties in New Jersey (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Psychiatry Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

David Brozyna, M.D. appears in the CMS NPPES registry as a Psychiatry Physician provider holding M.D. credentials at 85 ORIENT WAY, Rutherford, NJ, 07070, with a listed phone of (201) 939-5500. NPI 1114042462 was issued on 03/19/2007.

Medicare Part D records for calendar year 2023 show 979 prescription claims written by this provider, covering 77 Medicare beneficiaries and totaling roughly $98K in drug spend, split 10% brand-name and 90% generic by claim count.

Psychiatry Physician is a high-volume specialty nationwide, with 53,171 enrolled providers across 56 states and an average of 1,038 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

85 ORIENT WAY
Rutherford, NJ 07070

Provider Details

NPI 1114042462
Specialty Psychiatry Physician
Credentials M.D.
Gender Male
NPI Issued 03/19/2007

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for David Brozyna, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$297

Largest payer

Axsome Therapeutics, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

David Brozyna, M.D. - brand share 10.0%
Psychiatry Physician average

10% brand-name claims vs 90% generic, on 979 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

979
Total Claims
$98K
Total Drug Cost
77
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,584
Total Day Supply
46,917
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$56K
Generic Drug Cost
$42K

Patient Demographics

Average Patient Age
69.4 years
Avg HCC Risk Score
0.93
Gender Split
62% female / 38% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What David Brozyna, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Clonazepam
173
Duloxetine Hcl
57
Trazodone Hcl
56
Bupropion Xl
Bupropion Hcl
45
Dextroamphetamine-Amphetamine
Dextroamphetamine/Amphetamine
45
Risperidone
45
Aripiprazole
43
Citalopram Hbr
Citalopram Hydrobromide
36
Lamotrigine
35
Venlafaxine Hcl Er
Venlafaxine Hcl
29

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Psychiatry Physician Overview

How David Brozyna, M.D. fits within the Psychiatry Physician landscape nationally.

53,171
Psychiatry Physician Providers in US
56
States with Psychiatry Physician
1,038
Avg Claims per Provider

David Brozyna, M.D.'s 979 claims are below the specialty average of 1,038.

Nearby Psychiatry Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Brozyna.

Compare Psychiatry Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Psychiatry Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is David Brozyna, M.D.'s specialty?
David Brozyna, M.D. specializes in Psychiatry Physician and practices in Rutherford, New Jersey. Credentials: M.D..
How much does David Brozyna, M.D. prescribe under Medicare Part D?
In 2023, David Brozyna, M.D. wrote 979 Medicare Part D claims totaling $98K in drug costs for 77 beneficiaries.
Where is David Brozyna, M.D. located?
David Brozyna, M.D. is located at 85 ORIENT WAY, Rutherford, NJ, 07070. Phone: (201) 939-5500.
What is David Brozyna, M.D.'s NPI number?
David Brozyna, M.D.'s National Provider Identifier (NPI) is 1114042462, issued on 03/19/2007.
Does David Brozyna, M.D. prescribe more brand-name or generic drugs?
David Brozyna, M.D.'s prescribing is 10% brand-name and 90% generic drugs by claim count, with $56K in brand drug costs.
How many Psychiatry Physician providers are there in the US?
There are 53,171 Psychiatry Physician providers across 56 states in the US. The average Psychiatry Physician provider writes 1,038 Medicare Part D claims per year.
What drugs does David Brozyna, M.D. prescribe most often?
Based on 2023 Medicare Part D data, David Brozyna, M.D.'s most frequently prescribed drugs include Clonazepam, Duloxetine Hcl, Trazodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does David Brozyna, M.D. accept Medicare?
David Brozyna, M.D. appears in CMS Medicare data with 979 Part D claims and 77 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify David Brozyna, M.D.'s credentials?
David Brozyna, M.D.'s NPI is 1114042462 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.